Trial intelligence / Profile preview

PRP injection during laparoscopic endometriosis surgery for ovarian reserve

IRCT20191123045476N3Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Dec 2021
Countries
1
01

Overview

Phase 3, open-label trial of platelet-rich plasma in endometriosis (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Serum anti-Mullerian hormone level and Antral follicle count. Started Dec 2021; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

endometriosis

Beyond the preview

Go deeper on IRCT20191123045476N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191123045476N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call